320 related articles for article (PubMed ID: 23750121)
1. Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.
Pichler I; Del Greco M F; Gögele M; Lill CM; Bertram L; Do CB; Eriksson N; Foroud T; Myers RH; ; Nalls M; Keller MF; ; ; Benyamin B; Whitfield JB; ; Pramstaller PP; Hicks AA; Thompson JR; Minelli C
PLoS Med; 2013; 10(6):e1001462. PubMed ID: 23750121
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study-Brief Report.
Gill D; Del Greco M F; Walker AP; Srai SKS; Laffan MA; Minelli C
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1788-1792. PubMed ID: 28684612
[TBL] [Abstract][Full Text] [Related]
3. Associations of genetically determined iron status across the phenome: A mendelian randomization study.
Gill D; Benyamin B; Moore LSP; Monori G; Zhou A; Koskeridis F; Evangelou E; Laffan M; Walker AP; Tsilidis KK; Dehghan A; Elliott P; Hyppönen E; Tzoulaki I
PLoS Med; 2019 Jun; 16(6):e1002833. PubMed ID: 31220083
[TBL] [Abstract][Full Text] [Related]
4. Serum iron level and kidney function: a Mendelian randomization study.
Del Greco M F; Foco L; Pichler I; Eller P; Eller K; Benyamin B; Whitfield JB; ; ; Pramstaller PP; Thompson JR; Pattaro C; Minelli C
Nephrol Dial Transplant; 2017 Feb; 32(2):273-278. PubMed ID: 28186534
[TBL] [Abstract][Full Text] [Related]
5. Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.
Noyce AJ; Kia DA; Hemani G; Nicolas A; Price TR; De Pablo-Fernandez E; Haycock PC; Lewis PA; Foltynie T; Davey Smith G; ; Schrag A; Lees AJ; Hardy J; Singleton A; Nalls MA; Pearce N; Lawlor DA; Wood NW
PLoS Med; 2017 Jun; 14(6):e1002314. PubMed ID: 28609445
[TBL] [Abstract][Full Text] [Related]
6. Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease.
Kia DA; Noyce AJ; White J; Speed D; Nicolas A; ; Burgess S; Lawlor DA; Davey Smith G; Singleton A; Nalls MA; Sofat R; Wood NW
Ann Neurol; 2018 Aug; 84(2):191-199. PubMed ID: 30014513
[TBL] [Abstract][Full Text] [Related]
7. Genetically Predicted Serum Iron Status Is Associated with Altered Risk of Systemic Lupus Erythematosus among European Populations.
Ye D; Zhu Z; Huang H; Sun X; Liu B; Xu X; He Z; Li S; Wen C; Mao Y
J Nutr; 2021 Jun; 151(6):1473-1478. PubMed ID: 33693920
[TBL] [Abstract][Full Text] [Related]
8. Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration.
Wilman HR; Parisinos CA; Atabaki-Pasdar N; Kelly M; Thomas EL; Neubauer S; ; Mahajan A; Hingorani AD; Patel RS; Hemingway H; Franks PW; Bell JD; Banerjee R; Yaghootkar H
J Hepatol; 2019 Sep; 71(3):594-602. PubMed ID: 31226389
[TBL] [Abstract][Full Text] [Related]
9. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
Front Immunol; 2022; 13():956005. PubMed ID: 36159838
[TBL] [Abstract][Full Text] [Related]
10. Assessment of causal effects of physical activity on neurodegenerative diseases: A Mendelian randomization study.
Wu PF; Lu H; Zhou X; Liang X; Li R; Zhang W; Li D; Xia K
J Sport Health Sci; 2021 Jul; 10(4):454-461. PubMed ID: 33515719
[TBL] [Abstract][Full Text] [Related]
11. The Causal Effects of Blood Iron and Copper on Lipid Metabolism Diseases: Evidence from Phenome-Wide Mendelian Randomization Study.
Zhou J; Liu C; Francis M; Sun Y; Ryu MS; Grider A; Ye K
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33080795
[TBL] [Abstract][Full Text] [Related]
12. No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.
Larsson SC; Singleton AB; Nalls MA; Richards JB;
Mov Disord; 2017 Aug; 32(8):1249-1252. PubMed ID: 28594127
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional Mendelian randomization to explore the causal relationships between Sleep traits, Parkinson's disease and Amyotrophic lateral sclerosis.
Di H; Zhu Y; Xia W; Meng X; Zhang M; Xu M; Feng J; Tian Q; He Y; Cao S; Lu Z
Sleep Med; 2022 Aug; 96():42-49. PubMed ID: 35594779
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Obstructive sleep apnea and the risk of Alzheimer's disease and Parkinson disease: A Mendelian randomization study OSA, Alzheimer's disease and Parkinson disease.
Li J; Zhao L; Ding X; Cui X; Qi L; Chen Y
Sleep Med; 2022 Sep; 97():55-63. PubMed ID: 35724440
[TBL] [Abstract][Full Text] [Related]
16. Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach.
Kusters CDJ; Paul KC; Duarte Folle A; Keener AM; Bronstein JM; Bertram L; Hansen J; Horvath S; Sinsheimer JS; Lill CM; Ritz BR
Mov Disord; 2021 Oct; 36(10):2264-2272. PubMed ID: 34426982
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study.
Hartwig FP; Borges MC; Horta BL; Bowden J; Davey Smith G
JAMA Psychiatry; 2017 Dec; 74(12):1226-1233. PubMed ID: 29094161
[TBL] [Abstract][Full Text] [Related]
18. Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study.
Domenighetti C; Sugier PE; Ashok Kumar Sreelatha A; Schulte C; Grover S; Mohamed O; Portugal B; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Duga S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Kawamura Y; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Correia Guedes L; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen NL; Ran C; Belin AC; Puschmann A; Hellberg C; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Krüger R; Gasser T; Sharma M; Elbaz A;
Mov Disord; 2022 Apr; 37(4):857-864. PubMed ID: 34997937
[TBL] [Abstract][Full Text] [Related]
19. Appraising the Causal Association between Systemic Iron Status and Heart Failure Risk: A Mendelian Randomisation Study.
Wang X; Wang X; Gong Y; Chen X; Zhong D; Zhu J; Zhuang L; Gao J; Fu G; Lu X; Lai D
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014764
[TBL] [Abstract][Full Text] [Related]
20. The Parkinson's Disease Mendelian Randomization Research Portal.
Noyce AJ; Bandres-Ciga S; Kim J; Heilbron K; Kia D; Hemani G; Xue A; Lawlor DA; Smith GD; Duran R; Gan-Or Z; Blauwendraat C; Gibbs JR; ; Hinds DA; Yang J; Visscher P; Cuzick J; Morris H; Hardy J; Wood NW; Nalls MA; Singleton AB
Mov Disord; 2019 Dec; 34(12):1864-1872. PubMed ID: 31659794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
